233 Studies Now Enrolling
Menu
Search
Medical Condition
Displaying 1 - 3 of 3
Condition: Psychiatric Disorders / Bipolar Disorder
Investigator: Marzieh Majd, PharmD, PhD
Status: Currently Recruiting
We are recruiting adults with bipolar disorder, and adults with no psychiatric disorder, ages 18-60 years. As a participant in our study, you will be asked to attend one remote or in-person visit and one to two in-person visits. The following procedures will occur: Visit 1 (1 - 2.5 hrs): Clinical interview for overall psychiatric history as well as current…
Condition: Psychiatric Disorders / Bipolar Disorder
Investigator: Joshua Kantrowitz, Md
Status: Closed
We will evaluate the D-cycloserine (DCS) and lurasidone with MRI measurement of brain responses to DCS. DCS is a drug that works on the same brain receptor as ketamine. DCS is not approved by the FDA for bipolar depression. Study participants will receive a dose of lurasidone or placebo in one MRI and a dose of DCS in another, followed by an optional follow…
Condition: Blood Disorders / Anemia
Investigator: Katherine Ender, MD
Status: Closed
The main purpose of the study is to find out whether Triferic, when taken by mouth (orally) with Shohls solution, is safe and effective for the treatment of Iron Refractory Iron-Deficiency Anemia (IRIDA). The study drug, ferric pyrophosphate citrate (FPC), is also called Triferic. It is an iron salt that has been approved by the Food and Drug Administration…